鼻内菌体疗法克服了在肺部Pseudomonas aeruginosa感染中的抗体中和挑战
Dhammika Leshan Wannigama1,2,3,4,5,6, Jingping Shao7, Hongya Sun8
1Department of Infectious Diseases, Faculty of Medicine, Yamagata University, Yamagata, Japan. leshanwannigama@med.id.yamagata-u.ac.jp.
Archives of microbiology
|October 18, 2025
概括
针对Pseudomonas aeruginosa肺部感染的鼻腔菌体治疗显示出卓越的疗效. 这种输送途径提高了肺菌体的度,并降低了细菌负载,相比于腹腔内输送.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 菌体疗法为多药耐药性感染提供了一个有希望的替代方案.
- 菌体的全身管理可能会导致不理想的治疗结果.
- 肺部感染Pseudomonas aeruginosa的肺部感染带来了重大的临床挑战.
研究的目的:
- 为了比较治疗菌体KPP10的鼻内与腹腔内 (IP) 输送的分布,免疫反应和疗效.
- 评估KPP10在Pseudomonas aeruginosa肺部感染的小鼠模型中的有效性.
- 确定针对肺部细菌感染的菌体治疗的最佳途径.
主要方法:
- 建立了急性和慢性 Pseudomonas aeruginosa 肺部感染的小鼠模型.
- 治疗性菌体KPP10是通过鼻内或IP路线进行的.
- 评估了肺部的菌体分布,全身抗体反应 (IgG,IgM,IgA),细菌负载和生存率.
主要成果:
- 与IP交付相比,鼻内KPP10交付导致肺菌体局部化显著更高.
- 鼻内注射诱导了最小的全身抗体反应,而IP注射触发了大量的抗体产生.
- 在急性和慢性感染模型中,鼻内KPP10显著改善了生存率和减少了细菌负载.
- 持续的细菌清除被观察到与鼻内剂量,而IP治疗导致慢性感染的细菌反弹.
结论:
- 鼻内注射增强了肺菌体的局部化和对P. aeruginosa肺部感染的治疗疗效.
- 通过鼻内给药来最大限度地减少全身抗体反应,可以防止菌体中和,改善治疗结果.
- 鼻内菌体疗法代表了管理Pseudomonas aeruginosa肺部感染的潜在优越的给药途径.
更多相关视频
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
11.6K
16:56Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
Published on: August 30, 2014
17.5K
相关概念视频
Pneumonia IV: Management
713
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
713
Lytic Cycle of Bacteriophages
77.2K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
77.2K
Gene Regulation in Microbial Communities: Quorum Sensing
451
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
451
